Containment Cosmetics Licensing Sales 
The Pharma Data
NOVEMBER 4, 2020
Ltd (“Juyou”), a biotechnology company that develops and sells medical and cosmetic skincare products, for the commercialization and development of Pliaglis ® in mainland China (the “License Agreement”). million and US$1.8 About Juyou Bio – Technology Co. Juyou Bio-Technology Co.,
XTalks
AUGUST 2, 2023
Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. It contains the antiviral medications nirmatrelvir and ritonavir. billion in pharmaceutical sales from 2021. RELATED: Top 10 Medical Device Companies in 2023: Statistics and Trends 1) Pfizer By: Nadia Stec, M.Sc. billion, a 42.74
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Druggist
OCTOBER 25, 2020
Calamine lotion available in the UK for management of chickenpox symptoms contain a mixture of calamine (15%) and zinc oxide (5%). Nevertheless, calamine lotion is licensed in the UK for symptomatic relief of skin conditions including itchiness. Creams contain higher amounts of oil(s), and therefore are of thicker consistency.
The Pharma Data
NOVEMBER 26, 2020
in Daily E-Commerce Sales and recorded 103 individual E-Commerce Order Transactions (average order size: $92.37). We have also launched several new product offerings, most notably a dark chocolate coin (each infused with 20mg CBD) and some skin care/cosmetics selections. On Wednesday, November 25, 2020, the Company generated $9,514.49
FDA Law Blog
FEBRUARY 29, 2024
From there, the PTO notes that a PTE “determination is made based on the representations contained in the PTE application,” and that “35 U.S.C. § 156 or case law that would support extension of the ‘929 patent that claims the product despite revocation of the biologics license application.
The Pharma Data
NOVEMBER 4, 2020
Key findings of the research showed that patients with alopecia areata suffer significantly increased burden of illness, including a negative impact on many aspects of daily life, extending considerably beyond the cosmetic concerns of hair loss. License and research and development revenue. .
FDA Law Blog
JULY 26, 2022
Like all Guidance documents, it starts out with background, explaining that the Orange Book is FDA’s list of drug products approved under the Federal Food, Drug, and Cosmetic Act and contains patent and exclusivity information related to such products.
Expert insights. Personalized for you.
40 
Let's personalize your content